Affordable Access

Publisher Website

Mortality of People Living with HIV in Paris Area from 2011 to 2015.

  • Sellier, Pierre1
  • Hamet, Gwenn2
  • Brun, Alexandre2
  • Ponscarme, Diane3
  • De Castro, Nathalie3
  • Alexandre, Guylaine2
  • Rozenbaum, Willy2, 3
  • Molina, Jean-Michel3, 4
  • Abgrall, Sophie5
  • 1 Department of Internal Medicine, Saint-Louis-Lariboisière-Fernand Widal Hospital, AP-HP, Paris, France. , (France)
  • 2 COREVIH Ile de France Est, Saint-Louis Hospital, Paris, France. , (France)
  • 3 Department of Infectious Diseases, Saint-Louis-Lariboisière-Fernand Widal Hospital, AP-HP, Paris, France. , (France)
  • 4 University Paris Diderot, Paris, France. , (France)
  • 5 Department of Infectious Diseases, Avicenne Hospital, AP-HP, Bobigny, France. , (France)
Published Article
AIDS Research and Human Retroviruses
Mary Ann Liebert
Publication Date
Nov 05, 2019
DOI: 10.1089/AID.2019.0143
PMID: 31565958


In high-income countries, causes of death in people living with HIV (PLHIV) have changed. Three French national surveys from 2000 to 2010 showed a decrease in AIDS-related and an increase in non-AIDS-related deaths. Deaths notified in PLHIV followed between January 1, 2011 and December 31, 2015 in 1 of 13 participating hospitals northeast of Paris area were described. Risk factors for death were assessed, using a multivariable logistic regression model. Of 14,403 individuals, 295 died. Median age at death was 52 years (interquartile range = 47-60) and 77% were men. Sixty-seven individuals (23%) died from non-AIDS-defining nonviral hepatitis-related (NaNH) malignancy, 40 (14%) from AIDS, 34 (12%) from cardiovascular disease (CVD), 33 (11%) from non-AIDS infection, 21 (7%) from liver disease, and 12 (4%) from suicide. Men and women born in sub-Saharan Africa had a lower adjusted odds ratio (aOR) of dying than men having sex with men (MSM) born in France (0.70, 95% confidence interval = 0.45-1.09; and 0.45, 0.28-0.73, respectively). Risk factors for death were older age (aOR = 2.26, 1.36-3.77 for 40-49 years and 2.91, 1.75-4.84 for >50 years vs. 18-39 years), male intravenous drug users (IVDU) transmission (2.24, 1.42-3.54 vs. MSM born in France), AIDS (2.75, 2.10-3.59), antiretroviral therapy initiation in earlier periods, time since HIV diagnosis <1 year, low CD4 cell count nadir, hepatitis B virus and/or hepatitis C virus coinfection (1.69, 1.23-2.30), and psychiatric disorders (1.73, 1.27-2.38). Our study confirms the increasing frequency of non-AIDS-related deaths, mainly NaNH malignancies and CVD, in PLHIV, justifying overall and in some specific populations (psychiatric and IVDU) prevention and screening.

Report this publication


Seen <100 times